Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:1339-1346
Published online before print May 8, 2008, doi: 10.1161/ATVBAHA.108.165811
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
28/7/1339    most recent
ATVBAHA.108.165811v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fledderus, J. O.
Right arrow Articles by Horrevoets, A. J.G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fledderus, J. O.
Right arrow Articles by Horrevoets, A. J.G.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:1339.)
© 2008 American Heart Association, Inc.


Cell Biology and Signaling

KLF2 Primes the Antioxidant Transcription Factor Nrf2 for Activation in Endothelial Cells

Joost O. Fledderus; Reinier A. Boon; Oscar L. Volger; Hanna Hurttila; Seppo Ylä-Herttuala; Hans Pannekoek; Anna-Liisa Levonen; Anton J.G. Horrevoets

From the Department of Medical Biochemistry (J.O.F., R.A.B., O.L.V., H.P.), Academic Medical Center, University of Amsterdam, The Netherlands; the Department of Biotechnology and Molecular Medicine (H.H., S.Y.-H., A.-L.L.), A.I. Virtanen Institute, University of Kuopio, Finland; and the Department of Molecular Cell Biology and Immunology (O.L.V., A.J.G.H.), VU University Medical Center, Amsterdam, The Netherlands.

Correspondence to Dr Anton J.G. Horrevoets, Department of Molecular Cell Biology and Immunology, Room B244, VU University Medical Center, van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands. E-mail aj.horrevoets{at}vumc.nl

Objective— Atheroprotective blood flow induces expression of anti-inflammatory Krüppel-like factor 2 (KLF2) and activates antioxidant transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) in vascular endothelium. Previously, we obtained KLF2-induced gene expression profiles in ECs, containing several Nrf2 target genes. Our aim was to investigate the role of KLF2 in shear stress–mediated activation of Nrf2 in human umbilical vein endothelial cells (HUVECs).

Methods and Results— Expression of Nrf2 and its targets NAD(P)H dehydrogenase quinone 1 (NQO1) and heme oxygenase (HO-1) was elevated by shear and KLF2. KLF2 knockdown showed that shear-induced expression of NQO1 but not Nrf2 was dependent on KLF2. KLF2 overexpression in absence of flow resulted in more efficient activation of Nrf2 by tert-butyl hydroquinone (tBHQ) through enhanced nuclear localization, and promoted expression of a large panel of Nrf2-dependent genes resulting in superior protection against oxidative stress. Comparison of shear-, KLF2-, and Nrf2-induced transcriptomes showed that the majority of shear-modulated gene sets is influenced by KLF2 or Nrf2.

Conclusions— We report that KLF2 substantially enhances antioxidant activity of Nrf2 by increasing its nuclear localization and activation. The synergistic activity of these two transcription factors forms a major contribution to the shear stress–elicited transcriptome in endothelial cells.

The role of KLF2 in shear-induced Nrf2-dependent gene expression in HUVECs was studied. Nrf2-mediated antioxidant transcription was increased by KLF2 through enhanced Nrf2 nuclear localization and activation which resulted in an enhanced protection against oxidative stress. We report that KLF2 and Nrf2 give a major contribution to the antioxidant and antiinflammatory endothelial response to flow.


Key Words: endothelium • shear stress • KLF2 • oxidative stress • Nrf2




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
E. Kansanen, H.-K. Jyrkkanen, O. L. Volger, H. Leinonen, A. M. Kivela, S.-K. Hakkinen, S. R. Woodcock, F. J. Schopfer, A. J. Horrevoets, S. Yla-Herttuala, et al.
Nrf2-dependent and -independent Responses to Nitro-fatty Acids in Human Endothelial Cells: IDENTIFICATION OF HEAT SHOCK RESPONSE AS THE MAJOR PATHWAY ACTIVATED BY NITRO-OLEIC ACID
J. Biol. Chem., November 27, 2009; 284(48): 33233 - 33241.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. H. Heiss, D. Schachner, E. R. Werner, and V. M. Dirsch
Active NF-E2-related Factor (Nrf2) Contributes to Keep Endothelial NO Synthase (eNOS) in the Coupled State: ROLE OF REACTIVE OXYGEN SPECIES (ROS), eNOS, AND HEME OXYGENASE (HO-1) LEVELS
J. Biol. Chem., November 13, 2009; 284(46): 31579 - 31586.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Zakkar, K. Van der Heiden, L. A. Luong, H. Chaudhury, S. Cuhlmann, S. S. Hamdulay, R. Krams, I. Edirisinghe, I. Rahman, H. Carlsen, et al.
Activation of Nrf2 in Endothelial Cells Protects Arteries From Exhibiting a Proinflammatory State
Arterioscler Thromb Vasc Biol, November 1, 2009; 29(11): 1851 - 1857.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Ali, M. Zakkar, K. Karu, E. A. Lidington, S. S. Hamdulay, J. J. Boyle, M. Zloh, A. Bauer, D. O. Haskard, P. C. Evans, et al.
Induction of the Cytoprotective Enzyme Heme Oxygenase-1 by Statins Is Enhanced in Vascular Endothelium Exposed to Laminar Shear Stress and Impaired by Disturbed Flow
J. Biol. Chem., July 10, 2009; 284(28): 18882 - 18892.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. A. Calvert and M. R. Bennett
Restenosis Revisited
Circ. Res., April 10, 2009; 104(7): 823 - 825.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Rohlena, O. L. Volger, J. D. van Buul, L. H.P. Hekking, J. M. van Gils, P. I. Bonta, R. D. Fontijn, J. A. Post, P. L. Hordijk, and A. J.G. Horrevoets
Endothelial CD81 is a marker of early human atherosclerotic plaques and facilitates monocyte adhesion
Cardiovasc Res, January 1, 2009; 81(1): 187 - 196.
[Abstract] [Full Text] [PDF]